![Christine Silverstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Silverstein
Directeur/Membre du Conseil chez
ABEONA THERAPEUTICS INC.
Fortune : 796 033 $ au 31/05/2026
Profil
Christine Berni Silverstein currently works at Abeona Therapeutics, Inc., as Independent Director from 2020, National Investor Relations Institute, as Member, Women in Bio, Inc., as Member, Project 1972, Inc., as Member, and Artios Pharma Ltd., as Chief Financial Officer from 2024.
Ms. Silverstein also formerly worked at SCO Financial Group LLC, as Managing Director, Relmada Therapeutics, Inc., as Director-Investor Relations from 2014 to 2016, Marinus Pharmaceuticals, Inc., as Independent Director from 2023 to 2025, Excision BioTherapeutics, Inc., as Chief Financial Officer from 2021 to 2024, and Emendo Biotherapeutics, Inc., as Chief Financial Officer from 2020 to 2021.
Ms. Silverstein received her undergraduate degree from Peter J.
Tobin College of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 137 722 ( 0,24 % ) | 796 033 $ | 31/05/2026 |
Postes actifs de Christine Silverstein
| Sociétés | Poste | Début |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur/Membre du Conseil | 11/03/2020 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Corporate Officer/Principal | - |
Project 1972, Inc.
 Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Corporate Officer/Principal | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Directeur Financier/CFO | 01/02/2024 |
Anciens postes connus de Christine Silverstein
| Sociétés | Poste | Fin |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 11/02/2025 |
Excision BioTherapeutics, Inc.
 Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Directeur Financier/CFO | 01/01/2024 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Directeur Financier/CFO | 01/01/2021 |
| RELMADA THERAPEUTICS, INC. | Investor Relations Contact | 01/01/2016 |
| ░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Christine Silverstein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Finance |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Commercial Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Peter J. Tobin College of Business
 Peter J. Tobin College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Health Technology |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Commercial Services |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
